1. 3‑Oxoacid CoA transferase 1 as a therapeutic target gene for cisplatin-resistant ovarian cancer
   San‑Duk Yang et al, 2017, Oncology Letters CrossRef
2. Ovarian cancer stem cells and targeted therapy
   Vahideh Keyvani et al, 2019, Journal of Ovarian Research CrossRef
3. Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axis
   Sirichat Kaowinn et al, 2019, Biochemical and Biophysical Research Communications CrossRef
4. Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem‐like cells contributes to chemoresistance
   Etna Abad et al, 2021, The FEBS Journal CrossRef
5. Preliminary identification of endometrial cancer stem cells in vitro and in vivo
   Fan-Fei Kong et al, 2017, Biochemical and Biophysical Research Communications CrossRef
6. BRCA1 affects the resistance and stemness of SKOV3‐derived ovarian cancer stem cells by regulating autophagy
   Yue You et al, 2019, Cancer Medicine CrossRef
7. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers
   Haiyan Zhu et al, 2018, Clinical Cancer Research CrossRef
8. Characterization of the stemness potency of mammospheres isolated from the breast cancer cell lines
   Saghar Yousefnia et al, 2019, Tumor Biology CrossRef
9. Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA
   Guofang Chen et al, 2020, Oncogenesis CrossRef